REGENEREX PHARMA, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

REGENEREX PHARMA, INC. reported Cash And Cash Equivalents At Carrying Value of $653.0 thousand for the year ending 2025.

  • REGENEREX PHARMA, INC. showed an increase of +175,444.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from REGENEREX PHARMA, INC.'s annual report (Form 10-K), filed with the SEC on June 30, 2025.
  • XBRL data for this metric is available from 2010 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 13 years of available data (2010 to 2025), REGENEREX PHARMA, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 14,296.5%.
  • Historical annual values: Fiscal year 2025: $653.0 thousand | Fiscal year 2024: $372.00 | Fiscal year 2023: $1.1 thousand | Fiscal year 2022: $2.6 thousand | Fiscal year 2021: $6.9 thousand | Fiscal year 2020: $5.5 thousand | Fiscal year 2019: $88.5 thousand | Fiscal year 2018: $1.7 thousand | Fiscal year 2014: $1.3 thousand | Fiscal year 2013: $157.00 | Fiscal year 2012: $7.8 thousand | Fiscal year 2011: $1.7 thousand | Fiscal year 2010: $4.5 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: